Sadness and mourning in fibromyalgia, when the chronic patient comes to realize that his life has been transformed, giving way to a whole series of symptoms, it is very easy to fall into the sadness of acceptance of the disease.
When that sadness manifests itself in a medical consultation, administering a drug for the control of avoiding a depression can be harmful.
The patient needs to assimilate, combine and say goodbye to certain vital aspects of his life will make him fall into sadness. Sometimes even in despair. Other rabies, all part of a process of rehabilitation.
If there is time, a much needed time, all this will disappear to continue with the difficulties of the chronic disease.
Sadness and mourning in fibromyalgia
The patient needs his times and with his times he will learn, he will obtain resources to manage the disease.
The reading of this article, in its end, contrasts as many times the depression comes from the hand of the denial of time, compassion, memory and empathy causing exogenous depressions by the non-acceptance of the environment of their disability and illness.
Medicalize sadness is wrong
An editorial in ‘The Lancet’, a British medical journal, has expressed concern about the next edition of the fifth part of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) of the American Psychiatric Association. While previous editions of the DSM have highlighted the need to consider and exclude grief before the diagnosis of a major depressive disorder, the current draft of this fifth edition has not taken it into account.
According to the editorial, “in the DSM-5 draft there is no exclusion that considers and excludes grief; which means that feelings of deep sadness, loss, lack of sleep, crying, inability to concentrate, fatigue and lack of appetite, which last for more than 2 weeks after the death of a loved one, can be diagnosed as depression , rather than as a normal affliction reaction. ” The editorial adds that “medicalizing the feeling of sadness is dangerously simplistic and erroneous” .
Also, the editorial highlights that “although grief is associated with adverse health outcomes, both physical and mental, pharmacological interventions should be directed only to people at higher risk of developing a disorder, or those who develop a complicated grief or a depression, but not everyone.
Pain during mourning is not a disease
Pain during mourning is not a disease, it is a normal response to the death of a loved one, and putting a period of pain is not appropriate. Occasionally, prolonged affliction disorders or depression occur, to which the affected may need treatment, but most people who suffer the death of a loved one do not need medical treatment. For those who are grieving, time, compassion, remembrance and empathy are more effective than pills. “